In a significant stride towards revolutionising support for children with Autism Spectrum Disorder (ASD), Brightlobe has been awarded a prestigious grant from the UK Research and Innovation (UKRI). The project, titled "Evaluation of a novel tablet/game-based diagnostic support tool for the early detection of autism" and identified under the reference number 10027143, showcases an innovative approach to integrating novel neuropsychological tasks, immersive technologies and machine learning for a highly-sensitive diagnostic support tool.

‍

This tool will potentially reduce associated public healthcare costs by 68% and private patient costs by 84%. The technology is being co-developed with patient focus groups, leading UK/US developmental-behavioural paediatricians and commercial partners. The feasibility of the tool has already been confirmed alongside a SEND (special educational needs and disabilities centre) in a North London school. To move into the next stage of technology readiness, we must now conduct a preliminary technical evaluation.This project is designed to establish a baseline for performance on the assessment, examines its psychometric properties, and explore its utility as a tool to discover biomarkers for ASD.